Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 31 08 2018
accepted: 06 04 2019
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 14 1 2020
Statut: epublish

Résumé

Tuberculous lymphadenitis is the most frequent form of extra-pulmonary TB (EPTB) and accounts for a considerable proportion of all EPTB cases. We conducted a systematic review of articles that described the epidemiological features of TBLN in Africa. Any article that characterized TBLN cases with respect to demographic, exposure and clinical features were included. Article search was restricted to African countries and those published in English language irrespective of publication year. The articles were retrieved from the electronic database of PubMed, Scopus, Cochrane library and Lens.org. Random effect pooled prevalence with 95% CI was computed based on Dersimonian and Laird method. To stabilize the variance, Freeman-Tukey double arcsine root transformation was done. The data were analyzed using Stata 14. Of the total 833 articles retrieved, twenty-eight articles from 12 African countries fulfilled the eligibility criteria. A total of 6746 TBLN cases were identified. The majority of the cases, 4762 (70.6%) were from Ethiopia. Over 77% and 88% of identified TBLN were cervical in type and naïve to TB drugs. Among the total number of TBLN cases, 53% were female, 68% were in the age range of 15-44 years, 52% had a history of livestock exposure, 46% had a history of consuming raw milk/meat and 24% had history of BCG vaccination. The proportion of TBLN/HIV co-infection was much lower in Ethiopia (21%) than in other African countries (73%) and the overall African estimate (52%). Fever was recorded in 45%, night sweating in 55%, weight loss in 62% and cough for longer than two weeks in 32% of the TBLN cases. TBLN was more common in females than in males. The high prevalence of TBLN in Ethiopia did not show directional correlation with HIV. Population based prospective studies are warranted to better define the risk factors of TBLN in Africa.

Identifiants

pubmed: 31002716
doi: 10.1371/journal.pone.0215647
pii: PONE-D-18-25627
pmc: PMC6474617
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0215647

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Pathog. 2005 Sep;1(1):e5
pubmed: 16201017
Jpn J Infect Dis. 2013;66(4):263-8
pubmed: 23883834
Trop Doct. 1996 Apr;26(2):58-61
pubmed: 8685966
Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):294-7
pubmed: 9231200
Scand J Infect Dis. 2003;35(4):240-3
pubmed: 12839151
Vet J. 2011 Jun;188(3):359-61
pubmed: 20965132
Rev Esp Sanid Penit. 2015;17(1):3-11
pubmed: 25803112
PLoS One. 2013 Dec 09;8(12):e81918
pubmed: 24349151
Emerg Infect Dis. 2013 Jun;19(6):899-908
pubmed: 23735540
Scand J Infect Dis. 2009;41(6-7):462-8
pubmed: 19382003
Ecohealth. 2012 Jun;9(2):139-49
pubmed: 22526748
BMC Public Health. 2012 Jul 06;12:504
pubmed: 22770435
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
BMC Microbiol. 2015 Nov 21;15:268
pubmed: 26589993
Int J Tuberc Lung Dis. 2008 Sep;12(9):1030-6
pubmed: 18713500
Nat Rev Microbiol. 2006 Sep;4(9):670-81
pubmed: 16912712
Paediatr Respir Rev. 2001 Jun;2(2):113-9
pubmed: 12531057
Annu Rev Immunol. 2013;31:475-527
pubmed: 23516984
BMC Clin Pathol. 2014 Apr 02;14(1):14
pubmed: 24690344
Nat Rev Immunol. 2005 Oct;5(10):819-26
pubmed: 16200083
Vet Microbiol. 1994 May;40(1-2):137-51
pubmed: 8073621
Int J Mycobacteriol. 2015 Sep;4(3):196-201
pubmed: 27649866
BMC Infect Dis. 2015 Mar 03;15:112
pubmed: 25886866
Trends Microbiol. 2011 Oct;19(10):492-500
pubmed: 21831640
Przegl Epidemiol. 2002;56(2):205-16
pubmed: 12371352
Prev Vet Med. 2017 Nov 1;147:149-157
pubmed: 29254713
Int J Tuberc Lung Dis. 1997 Jun;1(3):215-9
pubmed: 9432366
CMAJ. 1999 Jun 1;160(11):1597-603
pubmed: 10374005
Adv Pediatr. 2006;53:279-322
pubmed: 17089872
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28084205
Tuberc Respir Dis (Seoul). 2015 Apr;78(2):47-55
pubmed: 25861336
J Rheumatol Suppl. 2014 May;91:11-6
pubmed: 24788995
Nat Med. 2017 Apr 7;23(4):398-401
pubmed: 28388608
Am Fam Physician. 2005 Nov 1;72(9):1761-8
pubmed: 16300038
Ethiop J Health Sci. 2014 Oct;24(4):311-8
pubmed: 25489195
PLoS One. 2013 Oct 02;8(10):e74517
pubmed: 24098337
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):148-50
pubmed: 26884490
Infect Genet Evol. 2013 Jun;16:433-40
pubmed: 23501297
Emerg Microbes Infect. 2018 Jun 6;7(1):102
pubmed: 29872046
Trop Doct. 1992 Jul;22(3):129-30
pubmed: 1641895
Clin Infect Dis. 2004 Jan 15;38(2):199-205
pubmed: 14699451
Ann Med Health Sci Res. 2016 Jan-Feb;6(1):44-9
pubmed: 27144076
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Int J Infect Dis. 2009 Sep;13(5):600-5
pubmed: 19111495
New Microbes New Infect. 2017 Oct 24;21:36-41
pubmed: 29675262
Pediatr Infect Dis J. 2006 Feb;25(2):142-6
pubmed: 16462291
PLoS One. 2016 Mar 07;11(3):e0150646
pubmed: 26950547
BMC Infect Dis. 2014 Dec 31;14:720
pubmed: 25551280
Thorax. 2018 Aug;73(8):785-787
pubmed: 29146867
Infect Genet Evol. 2017 Nov;55:251-259
pubmed: 28919549
Chest. 1991 May;99(5):1134-8
pubmed: 2019168
BMC Public Health. 2013 May 03;13:435
pubmed: 24499165
J Laryngol Otol. 2014 Jan;128(1):86-90
pubmed: 24423085
Cytopathology. 2002 Oct;13(5):284-90
pubmed: 12421444
Iran J Public Health. 2016 Mar;45(3):305-13
pubmed: 27141492
J Clin Microbiol. 2002 Nov;40(11):4230-4
pubmed: 12409403
Emerg Infect Dis. 2013 Mar;19(3):460-3
pubmed: 23622814
PLoS Genet. 2013;9(3):e1003318
pubmed: 23505379
Emerg Infect Dis. 2014 Jan;20(1):21-8
pubmed: 24520560
Clin Infect Dis. 2009 Nov 1;49(9):1350-7
pubmed: 19793000
J Infect Dis. 2005 Dec 15;192(12):2059-65
pubmed: 16288368
Pan Afr Med J. 2013 Aug 10;15:131
pubmed: 24319521
Br J Surg. 1975 Apr;62(4):323-5
pubmed: 1131513
BMC Public Health. 2014 Apr 07;14:319
pubmed: 24708793
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2869-73
pubmed: 16477032
East Afr Med J. 2003 Nov;80(11):559-63
pubmed: 15248672
Nat Rev Dis Primers. 2016 Oct 27;2:16076
pubmed: 27784885
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Daniel Mekonnen (D)

Department of Medical Microbiology, Immunology and Parasitology, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia.

Awoke Derbie (A)

Department of Medical Microbiology, Immunology and Parasitology, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
The Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.

Andargachew Abeje (A)

Geospatial Data and Technology Center, Bahir Dar University, Bahir Dar, Ethiopia.

Abebe Shumet (A)

Amhara Regional State Health Bureau, Felege Hiwot Referral Hospital, Bahir Dar, Ethiopia.

Endalkachew Nibret (E)

Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia.
Department of Biology, Bahir Dar University, Bahir Dar, Ethiopia.

Fantahun Biadglegne (F)

Department of Medical Microbiology, Immunology and Parasitology, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.

Abaineh Munshae (A)

Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia.
Department of Biology, Bahir Dar University, Bahir Dar, Ethiopia.

Kidist Bobosha (K)

Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Liya Wassie (L)

Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Stefan Berg (S)

Animal and Plant Health Agency, Weybridge, the United Kingdom.

Abraham Aseffa (A)

Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH